| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/12/2013 | CN102260256B Diaryl pyrazolo [3,4-b] pyridine heterocyclic compound as well as preparation method and drug application |
| 06/12/2013 | CN102258719B Preparation method of traditional Chinese medicinal oral liquid preparation for treating children's cold |
| 06/12/2013 | CN102250181B Polyhydroxy steroid compounds and purpose thereof |
| 06/12/2013 | CN102228636B Traditional Chinese medicine compositions for treating highly pathogenic reproductive and respiratory syndrome (PRRS) |
| 06/12/2013 | CN102210812B Compound Retapamulin medicinal membrane agent and preparation method thereof |
| 06/12/2013 | CN102206255B Sequences of mutants of Tat protein of human immunodeficiency virus type I and use thereof |
| 06/12/2013 | CN102178946B Application of baby hamster kidney(BHK)-21 cell serum-free suspension culture technology in foot-and-mouth disease vaccine production |
| 06/12/2013 | CN102166351B H1N1 influenza A vaccine and application thereof |
| 06/12/2013 | CN102086212B Antifungal agents of 2,3,4,5-tetrahydro-4H-benzo[b]thiopyrano[4,3,c]pyrazole-2-formamide derivatives |
| 06/12/2013 | CN102085311B Traditional Chinese medicinal composition for preventing or treating common cold and/or flu, method for preparing same and application thereof |
| 06/12/2013 | CN102078284B Gatifloxacin-containing gel for eyes and preparation method thereof |
| 06/12/2013 | CN102002489B MicroRNA for inhibiting multiplication of H1N1 influenza virus and application thereof |
| 06/12/2013 | CN101914135B Broad-spectrum chemokine receptor antagonistic polypeptide and application thereof |
| 06/12/2013 | CN101906418B Promoter for introducing gene into lymphocyte or blood cell and application thereof |
| 06/12/2013 | CN101897666B Pazufloxacin mesilate injection preparation and detection method thereof |
| 06/12/2013 | CN101768575B Construction of recombinant rabies virus of double-expression G gene and biological property analysis thereof |
| 06/12/2013 | CN101716195B Adsorption of black fungus extractant to endogenous and exogenous toxin of organism and application thereof |
| 06/12/2013 | CN101573135B Canine lyme disease vaccine |
| 06/12/2013 | CN101429184B Two-crystal type of substance of luteolin, production method, medicament composition and uses thereof |
| 06/12/2013 | CN101155594B Cream loaded with shellfish firing product powder and process for producing the same |
| 06/11/2013 | US8461134 Boron-containing small molecules |
| 06/11/2013 | US8460932 Method of treating a disorder by suicide gene therapy |
| 06/11/2013 | US8460701 Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide |
| 06/11/2013 | US8460675 Viral chemokine-antigen fusion proteins |
| 06/11/2013 | CA2583689C Multivalent canine vaccines against leptospira bratislava and other pathogens |
| 06/11/2013 | CA2533690C Use of a polyamine-poor composition for the production of a medical human food |
| 06/11/2013 | CA2484209C Protein kinase modulators and methods of use |
| 06/11/2013 | CA2469336C Guanidinium transport reagents and conjugates |
| 06/11/2013 | CA2467927C Antimicrobial polypeptides from pseudoplectania nigrella |
| 06/11/2013 | CA2428970C Method and apparatus for treatment of viral infection |
| 06/11/2013 | CA2427334C Methods and compositions for the treatment of diseases of the eye |
| 06/11/2013 | CA2426012C Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements |
| 06/11/2013 | CA2407603C Porphyromonas gingivalis recombinant proteins and truncations |
| 06/11/2013 | CA2400410C Antimicrobial compounds and formulations |
| 06/11/2013 | CA2388461C Highly conserved genes and their use to generate probes and primers for the detection of microorganisms |
| 06/06/2013 | WO2013082531A2 Broad spectrum influenza a neutralizing vaccines and d-peptidic compounds, and methods for making and using the same |
| 06/06/2013 | WO2013082237A1 Compositions and methods for the treatment of viral infections |
| 06/06/2013 | WO2013082003A1 Compositions and methods for treating hepatitis c virus |
| 06/06/2013 | WO2013081571A2 Isolated lyssavirus nucleic acid and protein sequences |
| 06/06/2013 | WO2013081448A2 Compositions for controlling ganoderma disease in plants and method thereof by using endophytic fungus, hendersonia ganoef1 |
| 06/06/2013 | WO2013081371A1 Binding molecule generated from human b-cells and capable of neutralizing influenza a viruses |
| 06/06/2013 | WO2013081284A1 Complex antibacterial composition for animals |
| 06/06/2013 | WO2013080222A1 Substituted pyridine derivatives as fabi inhibitors |
| 06/06/2013 | WO2013080167A1 Compounds for the treatment of tuberculosis |
| 06/06/2013 | WO2013079994A1 Lactobacillus paracasei subsp. paracasei, as an agent for inhibiting listeria monocytogenes in vivo infection |
| 06/06/2013 | WO2013079586A1 Carboxamide-substituted heteroaryl-pyrazoles and the use thereof |
| 06/06/2013 | WO2013078998A1 Novel slow-releasing ophthalmic compositions comprising povidone iodine |
| 06/06/2013 | WO2013078554A1 Compositions of tigecycline and uses thereof |
| 06/06/2013 | WO2013078540A1 Prophylactic compositions for management of microbial infections in patients with brain injury |
| 06/06/2013 | WO2013061101A9 Primycin and components thereof for use in the treatment or prevention of infections caused by specific pathogens |
| 06/06/2013 | WO2013057251A3 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 06/06/2013 | WO2013052095A3 Vaccine |
| 06/06/2013 | WO2012150183A8 Crystalline sodium salt of an hiv integrase inhibitor |
| 06/06/2013 | WO2012139106A3 Herpes simplex virus |
| 06/06/2013 | WO2012083185A8 Peptide-based in vivo sirna delivery system |
| 06/06/2013 | US20130143856 Novel antibiotic composition comprising flufenamic acid as an active ingredient |
| 06/06/2013 | US20130143281 Chimeric PUFA Polyketide Synthase Systems and Uses Thereof |
| 06/06/2013 | US20130142779 Treatment of Hi-Virus infections with oxidised blood proteins |
| 06/06/2013 | CA2857694A1 Peptide deformylase inhibitors |
| 06/06/2013 | CA2857666A1 Immunogenic composition comprising panton-valentine leukocidin (pvl) derived polypeptides |
| 06/06/2013 | CA2857441A1 Carboxamide-substituted heteroaryl-pyrazoles and their use |
| 06/06/2013 | CA2857226A1 Prophylactic compositions for management of microbial infections in patients with brain injury |
| 06/06/2013 | CA2856722A1 Antiviral jak inhibitors useful in treating or preventing retroviral and other viral infections |
| 06/06/2013 | CA2856529A1 Compositions and methods for treating hepatitis c virus |
| 06/06/2013 | CA2855906A1 Lactobacillus paracasei subsp. paracasei, as an agent for inhibiting listeria monocytogenes in vivo infection |
| 06/05/2013 | EP2599792A1 Antibody directed against PcrV |
| 06/05/2013 | EP2599503A2 Polymer conjugates of interferon beta-1A and uses thereof |
| 06/05/2013 | EP2599493A1 Antimicrobial activity enhancing agent |
| 06/05/2013 | EP2599489A1 AChE antisense deoxyoligonucleotide as an anti-inflammatory agent |
| 06/05/2013 | EP2599480A1 Compounds for the treatment of influenza |
| 06/05/2013 | EP2598631A1 Recombinant bacterium and uses thereof |
| 06/05/2013 | EP2598502A1 N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations. |
| 06/05/2013 | EP2598501A1 N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate |
| 06/05/2013 | EP2598498A1 Hetero-bicyclic derivatives as hcv inhibitors |
| 06/05/2013 | EP2598149A2 Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases |
| 06/05/2013 | EP2598134A1 Composition and method for photodynamic disinfection |
| 06/05/2013 | EP2598132A1 Composition for the treatment and prevention of herpes simplex labialis |
| 06/05/2013 | EP2598128A1 Anti- viral azide-containing compounds |
| 06/05/2013 | CN202961238U Traditional Chinese medicine liquor soaked toe socks for fundamentally treating barbiers |
| 06/05/2013 | CN103140486A Co-crystals and salts of ccr3-inhibitors |
| 06/05/2013 | CN103140474A Napht- 2 -ylacetic acid derivatives to treat aids |
| 06/05/2013 | CN103140242A Composition for oral use |
| 06/05/2013 | CN103140228A Benzoxaborole derivatives for treating bacterial infections |
| 06/05/2013 | CN103131687A Polyethylene glycol covalent modification lysostaphin and prepared method and application thereof |
| 06/05/2013 | CN103131686A Type two peptidoglycan recognition protein and preparation method and application thereof |
| 06/05/2013 | CN103131208A Coloring sterilization ointment for anatomic marks in clinical laboratory |
| 06/05/2013 | CN103130881A Novel drug resistant gene of Klebsiella pneumoniae |
| 06/05/2013 | CN103130877A Human immunodeficiency virus type I Tat protein mutant 1-37-site sequence and application thereof |
| 06/05/2013 | CN103130875A Method for extracting polymyxin B from fermentation broth |
| 06/05/2013 | CN103130873A Antituberculous CTL (Cytotoxic T Lymphocyte) epitope peptide with drug-resistant related efflux protein source for tuberculosis and application of epitope peptide |
| 06/05/2013 | CN103130865A Sophocarpidine, oxymatrine glycyrrhetinic acid double salt, and preparation method and use thereof |
| 06/05/2013 | CN103130853A Roxithromycin (ROX) crystal C type matter, preparation method thereof, medicine composition thereof and uses thereof |
| 06/05/2013 | CN103130852A Erythrocin A derivative, preparation method thereof, intermediate and application |
| 06/05/2013 | CN103130848A Macrolide antibacterial compounds, and preparation method and application thereof |
| 06/05/2013 | CN103130821A Cefuroxime lysine and preparation thereof |
| 06/05/2013 | CN103130806A Phenanthroindo(quio)lizidine alkaloid derivative, and preparation, anti-TMV activity, anti-HIV activity and anti-tumor activity thereof |
| 06/05/2013 | CN103130788A Pyrimidine amide compound, and preparation method, anti-HIV activity and anti-TMV activity thereof |
| 06/05/2013 | CN103130787A Pyrimidone amide compound, and preparation method, anti-HIV activity and anti-TMV activity thereof |
| 06/05/2013 | CN103130781A Lincosamides antibacterial drug capable of being used for treating bacterial infection |
| 06/05/2013 | CN103130735A Modulators of indoleamine 2,3-dioxygenase and methods of using the same |